| Structure | Chemical Name | CAS | MF |
|
Dromostanolone
|
58-19-5
|
C20H32O2
|
|
drosulfakinin II
|
117457-91-7
|
|
|
|
drosulfakinin 1
|
117457-90-6
|
|
|
|
drosulfakinin 0
|
117457-89-3
|
|
|
DRQAGFLGLGPWGKK
|
|
C79H118N22O19
|
|
|
drotrecogin alfa activated
|
|
|
|
|
DRPLA protein
|
|
|
|
DROTVERINE
|
|
C24H31NO4
|
|
Droxacin
|
35067-47-1
|
|
|
Droxinavir
|
159910-86-8
|
C29H51N5O4
|
|
DROXIDOPA
|
23651-95-8
|
C9H11NO5
|
|
Droxicam
|
90101-16-9
|
C16H11N3O5S
|
|
|
Droxidopa
|
50731-20-9
|
|
|
|
droxicainide
|
86797-92-4
|
|
|
Droxicainide
|
78421-12-2
|
C16H24N2O2
|
|
|
Droxicainide
|
78289-26-6
|
|
|
Droxypropine
|
15599-26-5
|
|
|
|
DRP-2 protein
|
|
|
|
|
drp35 protein
|
|
|
|
|
DRP-1 protein
|
|
|
|
|
DRP-3 protein
|
|
|
|
|
DRP1 protein, Xenopus
|
|
|
|
DRQGPEESDEFQS
|
|
C61H90N18O28
|
|
|
DR6 PRIMER PAIR
|
|
|
|
|
DSH 29
|
42514-10-3
|
|
|
|
DR3 PRIMER PAIR
|
|
|
|
|
Dr1 protein
|
|
|
|
DRQIKIWFQNRRMKWKKQLRRPSDRELSE
|
|
C169H277N57O44S
|
|
|
DRQIKIWFQNRRMKWKKTALDWSWLQTE
|
|
|
|
DRQIKIWFQNRRMKWKKVQRKRQKLMP
|
|
C164H275N55O35S2
|
|
DRQIKIFQNRRMKWKKRKIPTEDEY
|
|
C147H240N46O39S
|
|
DRQIKIWFQNRRMKWKKNGLLSGDEDFSS
|
|
C160H250N48O45S
|
|
|
DrrA protein
|
|
|
|
|
DrrA protein, Streptomyces peucetius
|
|
|
|
|
D1R, RAT, 9AA WITHIN 4TH EXTRACELLULAR DOMAIN
|
|
|
|
|
D1R, RAT, 13AA WITHIN CT CYTOPLASMIC DOMAIN
|
|
|
|
|
DSF-3 wax emulsion
|
|
|
|
|
DrrB protein, Streptomyces peucetius
|
|
|
|
|
2-4,D,SHEEPANTI-
|
|
|
|
|
dsg protein
|
|
|
|
DT12-18
|
59703-96-7
|
|
|
DT-3
|
|
C152H258N52O28S
|
|
|
DRR I protein
|
|
|
|
DSGVETS
|
|
C26H43N7O15
|
|
|
DSIF protein
|
|
|
|
|
drr1-1 protein
|
|
|
|
|
Dsh protein
|
|
|
|
|
D-RRR-ALPHATOCOPHEROLACETATE
|
|
|
|
|
D-RRR-ALPHATOCOPHERYLACETATE
|
|
|
|
DSIP
|
62568-57-4
|
C35H48N10O15
|
|
|
DSIP-immunoreactive peptide
|
|
|
|
|
DrtGEF protein
|
|
|
|
|
DRS2 protein
|
|
|
|
|
DRS-1 protein
|
|
|
|
|
Drs protein
|
|
|
|
|
DTA 35
|
63162-55-0
|
|
|
D-S-Isoamylcysteine
|
312746-71-7
|
C8H17NO2S
|
|
|
(DT)20 AA
|
|
|
|
|
Dtabellae Dried Yeast
|
|
|
|
|
(DT)20 AC
|
|
|
|
|
D-ructose-1-phosphate barium salt
|
|
C6H11BaO9P
|
|
DTAF
|
87137-43-7
|
C23H13Cl3N4O5
|
|
|
DTAF-Dextran
|
|
|
|
|
(DT)20 AG
|
|
|
|
|
D-tagatose 1,6-diphosphate
|
55529-38-9
|
|
|
|
DRUGABUSE
|
|
|
|
|
D-Tagatose 1-phosphate
|
|
C6H13O9P
|
|
D-TAGATOSE
|
87-81-0
|
C6H12O6
|
|
D-Tagatose, 6-azido-1,6-dideoxy-3,4-O-(1-methylethylidene)-
|
122194-05-2
|
C9H15N3O4
|
|
|
DRUGCONTAININGKAVALACTONES
|
|
|
|
|
Drug Carriers
|
|
|
|
|
Drug Combinations
|
|
|
|
|
DRUGDEVELOPMENT
|
|
|
|
|
drug delivery of chitosan carboxymethylcellulose complexes
|
|
|
|
|
DRTP1 protein
|
|
|
|
|
DruggableGenomeSet(PoolsOfSirnas)
|
|
|
|
|
DruggableGenomeSet(4SirnasPerGene)
|
|
|
|
|
DruggableGenomeSet(2SirnasPerGene)
|
|
|
|
|
DRT protein
|
|
|
|
|
DRUGINDUSTRY
|
|
|
|
|
Drug Implants
|
|
|
|
|
DR5 (TRAIL-R2, TRICK 2)/FC CHIMERA
|
|
|
|
|
DR3/TRAMP (death receptor-3)
|
|
|
|
|
drug release material
|
|
|
|
|
drug release materials of polyanhydride containing phosphorus
|
|
|
|
|
drug release copolymer of phosphorus containing diacid and bis (p-carboxyphenoxy) propane
|
|
|
|
|
drug release properties of polyanhydride release drug containing phosphonoformic acid ethylester in main chain
|
|
|
|
|
drug release system long chain fatty acid ester of cellulose
|
|
|
|
|
DRUGS
|
|
|
|
|
DSL
|
|
|
|
|
2-4D72%Sl
|
|
|
|
|
Drugs, Essential
|
|
|
|
|
Drugs, Non-Prescription
|
|
|
|
|
Drugs, Generic
|
|
|
|
|
Drugs, Chinese Herbal
|
|
|
|
|
Drugs, Investigational
|
|
|
|
|
DRUGS(GENERAL)
|
|
|
|
|
DRUGS(OTHER)
|
|
|
|
|
DT-827B
|
|
|
|
|
drug XX Z
|
152676-77-2
|
|